G01N 33/5091
For testing the pathological state of an organism
Official title: {for testing the pathological state of an organism}
G01N33/5091 (For testing the pathological state of an organism) appears on 1,710 US grants and 2,707 published applications in this corpus.
Search patents in G01N- Granted patents
- 1,710
- Published applications
- 2,707
- Assignees
- 1,348
- Inventors
- 5,429
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 2 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 6 | 0 |
| 1983 | 1 | 0 |
| 1984 | 6 | 0 |
| 1985 | 3 | 0 |
| 1986 | 3 | 0 |
| 1987 | 2 | 0 |
| 1988 | 11 | 0 |
| 1989 | 11 | 0 |
| 1990 | 12 | 0 |
| 1991 | 3 | 0 |
| 1992 | 4 | 0 |
| 1993 | 6 | 0 |
| 1994 | 11 | 0 |
| 1995 | 14 | 0 |
| 1996 | 22 | 0 |
| 1997 | 23 | 0 |
| 1998 | 58 | 0 |
| 1999 | 54 | 0 |
| 2000 | 56 | 0 |
| 2001 | 54 | 13 |
| 2002 | 47 | 93 |
| 2003 | 42 | 117 |
| 2004 | 32 | 112 |
| 2005 | 35 | 98 |
| 2006 | 27 | 87 |
| 2007 | 34 | 100 |
| 2008 | 21 | 63 |
| 2009 | 35 | 81 |
| 2010 | 41 | 87 |
| 2011 | 48 | 90 |
| 2012 | 35 | 99 |
| 2013 | 58 | 101 |
| 2014 | 66 | 161 |
| 2015 | 67 | 129 |
| 2016 | 74 | 117 |
| 2017 | 75 | 132 |
| 2018 | 87 | 145 |
| 2019 | 84 | 114 |
| 2020 | 78 | 132 |
| 2021 | 73 | 125 |
| 2022 | 48 | 124 |
| 2023 | 55 | 107 |
| 2024 | 77 | 111 |
| 2025 | 68 | 91 |
| 2026 | 37 | 78 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for selecting and treating cancer with FGFR3 inhibitors29 Sep 2026US 12,748,103 B2GeneCentric Therapeutics, Inc.
- Diagnostic methods for neural disorders15 Sep 2026US 12,736,528 B2Quiver Holdings Inc.
- System and method for deforming and analyzing particles8 Sep 2026US 12,730,057 B2The Regents of the University of California
- Methods for modulation of coronavirus infection1 Sep 2026US 12,724,031 B2Laboratory Corporation of America Holdings
- Compositions and methods for treating RAS-mutant cancers4 Aug 2026US 12,697,349 B2Algen Biotechnologies, Inc.
- Mhc class i molecules8 Oct 2026US 2026/0308228 A1Immudex ApS
- Biomarker composition for predicting efficacy of tuberculosis vaccine comprising CCL5 and use thereof24 Sep 2026US 2026/0286434 A1Industry-Academic Cooperation Foundation, Yonsei University
- Microbiota-associated markers of high-grade squamous intraepithelial lesions (hsil)17 Sep 2026US 2026/0276641 A1
- Self-assembling systems for modeling intracellular protein aggregation10 Sep 2026US 2026/0265322 A1
- Methods for Cancer Recurrence Detection and Treatment Thereof10 Sep 2026US 2026/0266837 A1Centre National De La Recherche Scientifique
Most cited
By later US patents
- High throughput screening assay systems in microscale fluidic devices877US 5,942,443 ACaliper Technologies Corp. · 1999
- Patient classification703US 6,763,307 B2Bioseek, Inc. · 2004
- High throughput screening assay systems in microscale fluidic devices692US 6,046,056 ACaliper Technologies Corp. · 2000
- Regulation of endogenous gene expression in cells using zinc finger proteins648US 6,534,261 B1Sangamo BioSciences, Inc. · 2003
- Neural network drug dosage estimation460US 6,658,396 B12003